
AnPac Bio-Medical Science Co., Ltd.
AnPac Bio-Medical Science Co., Ltd. (ANPC) Revenue
Annual & quarterly revenue history · segment & region breakdown
ANPC · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsAnPac Bio-Medical Science Co., Ltd. trailing twelve-month (TTM) revenue is $0.01B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income AnPac Bio-Medical Science Co., Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
AnPac Bio-Medical Science Co., Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from AnPac Bio-Medical Science Co., Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ANPC revenue · 4 questionsANPC's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · AnPac Bio-Medical Science Co., Ltd. SEC filings · GAAP · AnPac Bio-Medical Science Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026